Login to Your Account



SkyePharma's Asthma Drug Finally Approved in Europe

By Nuala Moran
Staff Writer

Wednesday, July 11, 2012
LONDON – The asthma treatment Flutiform finally won the seal of the European Commission recently, more than 12 years after SkyePharma plc set its sights on what it thought would be the relatively straightforward development of a combination product based on two marketed drugs.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription